Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02579187Phase 1Withdrawn
Phase 1, randomised, double-blind trial of pSil-miR200c and PMIS-miR-200a in Alveolar ridge resorption (4 arms). Primary endpoint: Percent of mineralized tissue upon histomorphometric analysis at 16 weeks. Planned start Dec 2025; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02579187.